Sachdev Amit 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Vertex (VRTX) EVP Amit Sachdev Surrenders 3,548 Shares for Taxes
What Happened
- Amit Sachdev, EVP and Chief Patient & External Affairs Officer at Vertex Pharmaceuticals (VRTX), had 3,548 shares disposed on 2026-02-13 as payment to cover tax liability. The shares were valued at $487.76 each for a total of approximately $1,730,572.
- This was a share withholding to satisfy tax obligations (not an open-market sale), a routine administrative step following an equity award or option exercise.
Key Details
- Transaction date: 2026-02-13. Price per share: $487.76. Total value: ~$1,730,572.
- Transaction type/code: F — payment of exercise price or tax liability (shares withheld).
- Shares owned after the transaction: not provided in the summary data here; see the SEC Form 4 for the insider’s reported holdings.
- Filing date: 2026-02-18 (five days after the transaction). Form 4s are normally due within two business days of the transaction; this filing appears later than that window—see the full filing for any timeliness notes or explanations.
Context
- Withheld shares used to pay taxes are common after option exercises or restricted stock vesting and generally reflect routine tax withholding rather than a decision to liquidate shares on the open market.
- For a complete picture (current holdings, whether this was tied to a specific grant/exercise, and any 10b5-1 plan or additional footnotes), consult the full SEC Form 4 (Accession: 0000875320-26-000074).
Insider Transaction Report
Form 4
Sachdev Amit
EVP Chief Patient & Ext Af Off
Transactions
- Tax Payment
Common Stock
2026-02-13$487.76/sh−3,548$1,730,572→ 65,393 total
Holdings
- 9,301(indirect: By Trust)
Common Stock
- 882(indirect: By 401(k))
Common Stock
Signature
/s/ Christiana Stevenson, Attorney-in-Fact|2026-02-18